Research ArticleArticle

High Risk of Ischemic Heart Disease in Patients with Lupus Nephritis

MIKKEL FAURSCHOU, LENE MELLEMKJAER, HENRIK STARKLINT, ANNE-LISE KAMPER, ULRIK TARP, ANNE VOSS and SØREN JACOBSEN
The Journal of Rheumatology November 2011, 38 (11) 2400-2405; DOI: https://doi.org/10.3899/jrheum.110329

REFERENCES

  1. 1.↵
    1. Bernatsky S,
    2. Boivin JF,
    3. Joseph L,
    4. Manzi S,
    5. Ginzler E,
    6. Gladman DD,
    7. et al.
    Mortality in systemic lupus erythematosus. Arthritis Rheum 2006;54:2550–7.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Urowitz MB,
    2. Bookman AA,
    3. Koehler BE,
    4. Gordon DA,
    5. Smythe HA,
    6. Ogryzlo MA
    . The bimodal mortality pattern of systemic lupus erythematosus. Am J Med 1976;60:221–5.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Petri M,
    2. Perez-Gutthann S,
    3. Spence D,
    4. Hochberg MC
    . Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Am J Med 1992;93:513–9.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Fischer LM,
    2. Schlienger RG,
    3. Matter C,
    4. Jick H,
    5. Meier CR
    . Effect of rheumatoid arthritis or systemic lupus erythematosus on the risk of first-time acute myocardial infarction. Am J Cardiol 2004; 93:198–200.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Hak AE,
    2. Karlson EW,
    3. Feskanich D,
    4. Stampfer MJ,
    5. Costenbader KH
    . Systemic lupus erythematosus and the risk of cardiovascular disease: results from the Nurses’ Health Study. Arthritis Rheum 2009;61:1396–402.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Ward MM
    . Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus. Arthritis Rheum 1999;42:338–46.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Esdaile JM,
    2. Abrahamowicz M,
    3. Grodzicky T,
    4. Li Y,
    5. Panaritis C,
    6. du Berger R,
    7. et al.
    Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 2001;44:2331–7.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Manzi S,
    2. Meilahn EN,
    3. Rairie JE,
    4. Conte CG,
    5. Medsger TA Jr.,
    6. Jansen-McWilliams L,
    7. et al.
    Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 1997;145:408–15.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Bjornadal L,
    2. Yin L,
    3. Granath F,
    4. Klareskog L,
    5. Ekbom A
    . Cardiovascular disease a hazard despite improved prognosis in patients with systemic lupus erythematosus: results from a Swedish population based study 1964–95. J Rheumatol 2004;31:713–9.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Smith RM,
    2. Clatworthy MR,
    3. Jayne DR
    . Biological therapy for lupus nephritis-tribulations and trials. Nat Rev Rheumatol 2010;6:547–52.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Houssiau FA,
    2. Ginzler EM
    . Current treatment of lupus nephritis. Lupus 2008;17:426–30.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Zhang W,
    2. Aghdassi E,
    3. Reich HN,
    4. Su J,
    5. Lou W,
    6. Landolt-Marticorena C,
    7. et al.
    Glomerular filtration rate predicts arterial events in women with systemic lupus erythematosus. Rheumatology 2011;50:799–805.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. Urowitz MB,
    2. Ibanez D,
    3. Gladman DD
    . Atherosclerotic vascular events in a single large lupus cohort: prevalence and risk factors. J Rheumatol 2007;34:70–5.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Wells DK,
    2. Ward MM
    . Nephritis and the risk of acute myocardial infarction in patients with systemic lupus erythematosus. Clin Exp Rheumatol 2010;28:223–9.
    OpenUrlPubMed
  15. 15.↵
    1. Pons-Estel GJ,
    2. Gonzalez LA,
    3. Zhang J,
    4. Burgos PI,
    5. Reveille JD,
    6. Vila LM,
    7. et al.
    Predictors of cardiovascular damage in patients with systemic lupus erythematosus: data from LUMINA (LXVIII), a multiethnic US cohort. Rheumatology 2009;48:817–22.
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    1. Sarnak MJ,
    2. Levey AS,
    3. Schoolwerth AC,
    4. Coresh J,
    5. Culleton B,
    6. Hamm LL,
    7. et al.
    Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension 2003;42:1050–65.
    OpenUrlFREE Full Text
  17. 17.↵
    1. Go AS,
    2. Chertow GM,
    3. Fan D,
    4. McCulloch CE,
    5. Hsu CY
    . Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351:1296–305.
    OpenUrlCrossRefPubMed
  18. 18.↵
    1. Jacobsen S,
    2. Petersen J,
    3. Ullman S,
    4. Junker P,
    5. Voss A,
    6. Rasmussen JM,
    7. et al.
    A multicentre study of 513 Danish patients with systemic lupus erythematosus. I. Disease manifestations and analyses of clinical subsets. Clin Rheumatol 1998;17:468–77.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Jacobsen S,
    2. Petersen J,
    3. Ullman S,
    4. Junker P,
    5. Voss A,
    6. Rasmussen JM,
    7. et al.
    A multicentre study of 513 Danish patients with systemic lupus erythematosus. II. Disease mortality and clinical factors of prognostic value. Clin Rheumatol 1998;17:478–84.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Tan EM,
    2. Cohen AS,
    3. Fries JF,
    4. Masi AT,
    5. McShane DJ,
    6. Rothfield NF,
    7. et al.
    The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271–7.
    OpenUrlPubMed
  21. 21.↵
    1. Churg J,
    2. Sobin LH
    . Renal disease: classification and atlas of glomerular disease. Tokyo: Igaku-Shoin; 1982:127–31.
  22. 22.↵
    1. Austin HA III.,
    2. Muenz LR,
    3. Joyce KM,
    4. Antonovych TA,
    5. Kullick ME,
    6. Klippel JH,
    7. et al.
    Prognostic factors in lupus nephritis. Contribution of renal histologic data. Am J Med 1983;75:382–91.
    OpenUrlCrossRefPubMed
  23. 23.↵
    1. Juel K,
    2. Helweg-Larsen K
    . The Danish registers of causes of death. Dan Med Bull 1999;46:354–7.
    OpenUrlPubMed
  24. 24.↵
    1. Hommel K,
    2. Rasmussen S,
    3. Madsen M,
    4. Kamper AL
    . The Danish Registry on Regular Dialysis and Transplantation: completeness and validity of incident patient registration. Nephrol Dial Transplant 2010;25:947–51.
    OpenUrlAbstract/FREE Full Text
  25. 25.↵
    1. Faurschou M,
    2. Mellemkjaer L,
    3. Sorensen IJ,
    4. Svalgaard TB,
    5. Dreyer L,
    6. Baslund B
    . Increased morbidity from ischemic heart disease in patients with Wegener’s granulomatosis. Arthritis Rheum 2009;60:1187–92.
    OpenUrlCrossRefPubMed
  26. 26.↵
    1. Andersen TF,
    2. Madsen M,
    3. Jorgensen J,
    4. Mellemkjaer L,
    5. Olsen JH
    . The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999;46:263–8.
    OpenUrlPubMed
  27. 27.↵
    1. Madsen M,
    2. Balling H,
    3. Eriksen LS
    . The validity of the diagnosis of acute myocardial infarction in 2 registries: the Heart Registry compared to the National Patient Registry [Danish]. Ugeskr Laeger 1990;152:308–14.
    OpenUrlPubMed
  28. 28.↵
    1. Hojris I,
    2. Overgaard M,
    3. Christensen JJ,
    4. Overgaard J
    . Morbidity and mortality of ischaemic heart disease in high-risk breast-cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: analysis of DBCG 82b and 82c randomised trials. Radiotherapy Committee of the Danish Breast Cancer Cooperative Group. Lancet 1999;354:1425–30.
    OpenUrlCrossRefPubMed
  29. 29.↵
    1. Mancia G,
    2. De Backer G,
    3. Dominiczak A,
    4. Cifkova R,
    5. Fagard R,
    6. Germano G,
    7. et al.
    2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007;25:1105–87.
    OpenUrlCrossRefPubMed
  30. 30.↵
    1. Faurschou M,
    2. Dreyer L,
    3. Kamper AL,
    4. Starklint H,
    5. Jacobsen S
    . Long-term mortality and renal outcome in a cohort of 100 patients with lupus nephritis. Arthritis Care Res 2010;62:873–80.
    OpenUrlCrossRef
  31. 31.↵
    1. Haque S,
    2. Bruce IN
    . Therapy insight: systemic lupus erythematosus as a risk factor for cardiovascular disease. Nat Clin Pract Cardiovasc Med 2005;2:423–30.
    OpenUrlCrossRefPubMed
  32. 32.↵
    1. Abildstrom SZ,
    2. Rasmussen S,
    3. Rosen M,
    4. Madsen M
    . Trends in incidence and case fatality rates of acute myocardial infarction in Denmark and Sweden. Heart 2003;89:507–11.
    OpenUrlAbstract/FREE Full Text
  33. 33.↵
    1. Foley RN,
    2. Parfrey PS,
    3. Sarnak MJ
    . Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998;32Suppl:S112–9.
    OpenUrlCrossRefPubMed
  34. 34.↵
    1. Roman MJ,
    2. Shanker BA,
    3. Davis A,
    4. Lockshin MD,
    5. Sammaritano L,
    6. Simantov R,
    7. et al.
    Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003;349:2399–406.
    OpenUrlCrossRefPubMed
  35. 35.↵
    1. Telles RW,
    2. Lanna CC,
    3. Ferreira GA,
    4. Souza AJ,
    5. Navarro TP,
    6. Ribeiro AL
    . Carotid atherosclerotic alterations in systemic lupus erythematosus patients treated at a Brazilian university setting. Lupus 2008;17:105–13.
    OpenUrlAbstract/FREE Full Text
  36. 36.↵
    1. Weening JJ,
    2. D’Agati VD,
    3. Schwartz MM,
    4. Seshan SV,
    5. Alpers CE,
    6. Appel GB,
    7. et al.
    The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 2004;65:521–30.
    OpenUrlCrossRefPubMed
  37. 37.↵
    1. Korbet SM,
    2. Lewis EJ,
    3. Schwartz MM,
    4. Reichlin M,
    5. Evans J,
    6. Rohde RD
    . Factors predictive of outcome in severe lupus nephritis. Lupus Nephritis Collaborative Study Group. Am J Kidney Dis 2000;35:904–14.
    OpenUrlPubMed
  38. 38.↵
    1. Najafi CC,
    2. Korbet SM,
    3. Lewis EJ,
    4. Schwartz MM,
    5. Reichlin M,
    6. Evans J
    . Significance of histologic patterns of glomerular injury upon long-term prognosis in severe lupus glomerulonephritis. Kidney Int 2001;59:2156–63.
    OpenUrlPubMed
  39. 39.↵
    K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39Suppl 1:S1–266.
    OpenUrlCrossRefPubMed
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

 Request Permissions

Bookmark this article

Jump to section